tradingkey.logo

Surmodics Inc

SRDX
26.790USD
+0.370+1.40%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
383.04MCap. mercado
PérdidaP/E TTM

Más Datos de Surmodics Inc Compañía

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Información de Surmodics Inc

Símbolo de cotizaciónSRDX
Nombre de la empresaSurmodics Inc
Fecha de salida a bolsaMar 04, 1998
Director ejecutivoMr. Gary R. Maharaj
Número de empleados389
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 04
Dirección9924 W 74th St
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55344
Teléfono19525007000
Sitio Webhttps://www.surmodics.com/
Símbolo de cotizaciónSRDX
Fecha de salida a bolsaMar 04, 1998
Director ejecutivoMr. Gary R. Maharaj

Ejecutivos de Surmodics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Mr. Jose H. Bedoya
Mr. Jose H. Bedoya
Independent Director
Independent Director
30.01K
+3.63%
Mr. Gordon S. Weber, J.D.
Mr. Gordon S. Weber, J.D.
Senior Vice President - Legal, General Counsel, Secretary
Senior Vice President - Legal, General Counsel, Secretary
21.04K
-1.49%
Ms. Lisa Wipperman Heine
Ms. Lisa Wipperman Heine
Independent Director
Independent Director
13.98K
+3.90%
Ms. Teryl L.W. Sides
Ms. Teryl L.W. Sides
Senior Vice President, President - Vascular Interventions
Senior Vice President, President - Vascular Interventions
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Otro
70.52%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Otro
70.52%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
39.31%
Investment Advisor
24.73%
Hedge Fund
22.33%
Research Firm
4.06%
Individual Investor
3.88%
Bank and Trust
0.51%
Sovereign Wealth Fund
0.22%
Pension Fund
0.09%
Insurance Company
0.03%
Otro
4.84%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
312
12.95M
90.59%
-4.14M
2025Q2
321
12.64M
88.41%
-4.03M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
1.02M
7.13%
-27.06K
-2.58%
Jun 30, 2025
AllianceBernstein L.P.
850.47K
5.95%
+1.12K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
810.18K
5.67%
+11.51K
+1.44%
Jun 30, 2025
Soleus Capital Management, L.P.
789.06K
5.52%
--
--
Jun 30, 2025
Gabelli Funds, LLC
745.83K
5.22%
+26.83K
+3.73%
Jun 30, 2025
Trium Capital LLP
716.78K
5.01%
+716.78K
--
Jul 11, 2025
UBS Financial Services, Inc.
422.72K
2.96%
+356.98K
+543.00%
Jun 30, 2025
Hudson Bay Capital Management LP
400.00K
2.8%
-64.97K
-13.97%
Jun 30, 2025
Qube Research & Technologies Ltd
393.98K
2.76%
+4.80K
+1.23%
Jun 30, 2025
Readystate Asset Management LP
433.61K
3.03%
+433.61K
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
First Trust Merger Arbitrage ETF
4.36%
SPDR S&P Health Care Equipment ETF
0.45%
Inspire Small/Mid Cap ESG ETF
0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
iShares Micro-Cap ETF
0.08%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
ProShares Hedge Replication ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.02%
Ver más
First Trust Merger Arbitrage ETF
Proporción4.36%
SPDR S&P Health Care Equipment ETF
Proporción0.45%
Inspire Small/Mid Cap ESG ETF
Proporción0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.08%
iShares Micro-Cap ETF
Proporción0.08%
iShares U.S. Medical Devices ETF
Proporción0.05%
Franklin US Small Cap Multifactor Index ETF
Proporción0.05%
iShares Russell 2000 Growth ETF
Proporción0.03%
ProShares Hedge Replication ETF
Proporción0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.02%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI